SEC Form 4 · accession 0001209191-18-036515
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rory B Riggs
Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2018 | A | 3,700 | $0.00 | A | 382,900 | D | |
| Common StockF2 | holding | — | — | — | 605,713 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $55.30 | Jun 5, 2018 | A | 6,000 | A | — | Jun 5, 2028 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1Represents the grant of restricted stock units that vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders.
- F2Shares are held by New Ventures I, LLC. The reporting person is Managing Member of New Ventures I, LLC and has voting and investment control with respect to the shares held by New Ventures I, LLC.
- F3Options vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders.